Related Experiment Video
Updated: Jun 14, 2026

Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using Poly(I:C) to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
Mumps outbreak in the Republic of Moldova, 2007-2008
Norbert G Schwarz1, Helen Bernard, Anatolie Melnic
1Institut de Veille Sanitaire, Départment des Maladies Infectieuses, Paris, France.
Background:
Moldova experienced a nationwide mumps outbreak between 2007 and 2008. Single-dose monovalent mumps vaccination at 15 to 18 months was introduced in 1983, replaced by a 2-dose MMR schedule at age 1 and 6 to 7 years in 2002. We investigated the outbreak to quantify its extent, explore the role of primary and secondary vaccine failure, and provide control recommendations.
Methods:
We analyzed national mumps surveillance and vaccination coverage data to estimate vaccine effectiveness (VE) using the screening method. A retrospective cohort study in 5 educational institutions was conducted to determine age-specific attack rates (ARs) and VE. We compared vaccine strain-specific ARs. Isolation and genotyping of mumps virus strains were performed.
Results:
Of 31,142 cases reported during October 2007 and July 2008, 80% were in 15- to 24-year-olds. Of cases with information (66%), 92% were vaccinated once, 4% twice. One-dose mumps VE estimates based on surveillance data over 1997-2001 declined from 91% (95% CI: 88%-92%) in 2-year-olds to 72% (70%-74%) in 15- to 19-year-olds. In the cohort study (n = 1589), VE was -40% (-120% to 20%) for 1 dose. For 2 doses it was 62% (-43% to 90%) in 13- to 15-year-olds. ARs were higher in individuals vaccinated with Urabe strains (43%) than with Leningrad-Zagreb strains (14%, P < 0.001). Mumps virus genotype G5 was identified.
Conclusions:
Low effectiveness of single-dose mumps vaccination was the main cause of the outbreak. Waning immunity may have contributed to this. The risk of mumps in 2-dose vaccinees was low. Other countries in which large population groups have received <2 doses of mumps vaccine may face similar outbreaks.
Insights
Low effectiveness of single-dose mumps vaccination led to a nationwide outbreak. Two doses of the MMR vaccine were found to be effective, offering crucial protection against mumps.
Area of Science:
- Epidemiology
- Immunology
- Public Health
Background:
- Moldova experienced a widespread mumps outbreak from 2007-2008.
- Vaccination policies shifted from single-dose mumps vaccine (1983) to a two-dose MMR schedule (2002).
Purpose of the Study:
- To quantify the extent of the mumps outbreak.
- To investigate the roles of primary and secondary vaccine failure.
- To provide evidence-based control recommendations.
Main Methods:
- Analysis of national mumps surveillance and vaccination data.
- Estimation of vaccine effectiveness (VE) using the screening method.
- Retrospective cohort study in educational institutions to determine age-specific attack rates (ARs) and VE.
- Mumps virus strain isolation and genotyping.
Main Results:
- Over 31,000 mumps cases were reported, predominantly in 15- to 24-year-olds.
- The majority of cases (92%) had received only one dose of the mumps vaccine.
- Single-dose mumps vaccine effectiveness declined significantly with age, from 91% in 2-year-olds to 72% in 15- to 19-year-olds.
- Two-dose MMR vaccine effectiveness was 62% in 13- to 15-year-olds.
- Mumps virus genotype G5 was identified, with higher attack rates observed with Urabe strains compared to Leningrad-Zagreb strains.
Conclusions:
- The primary driver of the mumps outbreak was the low effectiveness of the single-dose mumps vaccination strategy.
- Waning immunity may have contributed to the outbreak's dynamics.
- The risk of mumps infection remained low among individuals who received two doses of the vaccine.
- Countries with substantial populations receiving fewer than two mumps vaccine doses may be susceptible to similar outbreaks.
Related Concept Videos
Cytomegalovirus Disease
Viral Meningitis
Infectious Diseases and Their Occurrence
Investigation of Disease Outbreaks
Vaccinations
Smallpox

